Harmony Biosciences
HRMY
$31.69
Share price
4.69%
Change (1 day)
-5.54%
Change (1 year)
Categories
Harmony Biosciences (HRMY) - Cash on Hand
Cash on Hand as of December 2023 : $0.35 B
According to Harmony Biosciences's latest financial reports the company has $0.35 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Harmony Biosciences - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.35 B | 9.39% |
| 2022-12-31 | $0.32 B | 37.9% |
| 2021-12-31 | $0.23 B | 2.48% |
| 2020-12-31 | $0.22 B | 834.83% |
| 2019-12-31 | $24.45 M | -70.72% |
| 2018-12-31 | $83.52 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -72.87% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -94.11% | 🇺🇸 USA |